证券之星消息，7月30日动物保健板块较上一交易日下跌0.46%，生物股份领跌。当日上证指数报收于 3615.72，上涨0.17%。深证成指报收于11203.03，下跌0.77%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 871970 | 大禹生物 | 10.98 | 7.65% | 7.08万 | 7555.51万 | | | 002868 | *ST绿康 | 26.73 | 4.99% | 2.78万 | 7294.48万 | | | 839729 | 永顺生物 | 10.02 | 1.83% | 4.19万 | 4168.45万 | | | 300871 | 回盛生物 | 22.22 | 1.37% | 16.18万 | | 3.63亿 | | 002688 | 金河生物 | 7.22 | 0.84% | 42.68万 | | 3.06亿 | | 688098 | 申联生物 | 6.90 | 0.73% | 10.01万 | 6919.84 ...

从资金流向上来看，当日动物保健板块主力资金净流出9984.08万元，游资资金净流出2164.17万元，散户 资金净流入1.21亿元。动物保健板块个股资金流向见下表： 证券之星消息，7月29日动物保健板块较上一交易日下跌0.5%，驱动力领跌。当日上证指数报收于 3609.71，上涨0.33%。深证成指报收于11289.41，上涨0.64%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 002868 | *ST绿康 | 25.46 | 2.91% | 2.25万 | | 5731.13万 | | 688098 | 申联生物 | 6.85 | 1.33% | 10.41万 | | 7137.24万 | | 603566 | 普莱柯 | 15.23 | 0.40% | 5.03万 | | 7579.24万 | | 002688 | 金河生物 | 7.16 | 0.14% | 36.15万 | | 2.59亿 | | 688526 | 科前生物 | 17.2 ...

Investment Rating - The industry rating is "Recommended" [3] Core Insights - The report emphasizes the need for high-quality development in the pig farming industry, focusing on improving efficiency and quality. It highlights the importance of capacity control and the encouragement of large enterprises to collaborate with smaller farms to share industry benefits [2][12] - In the planting industry, the report discusses the promotion of new varieties and technologies to enhance crop yields, particularly in the context of food security. It predicts a continued acceleration in the commercialization of genetically modified crops [1][11] Summary by Sections Planting Industry - The Ministry of Agriculture and Rural Affairs is working on a directory for superior crop varieties by 2025, focusing on enhancing yields and meeting current production needs [1][11] - The report identifies potential beneficiaries in the planting sector, including Beidahuang and Su-Kun Agricultural Development, and recommends companies with strong advantages in seed development such as Longping High-Tech and Denge Seed Industry [1][11] Pig Farming - The average price of external three-way cross pigs is 14.29 CNY/kg, showing a week-on-week decrease of 1.20%. The overall supply exceeds demand, leading to a forecast of continued price declines [2][12] - The report notes a decrease in the number of breeding sows, with a total of 40.43 million as of June 2025, down by 370,000 from the previous year [2][12] - Recommended companies in the pig farming sector include Dekang Agriculture, Jingji Zhino, Muyuan Foods, and Wens Foodstuff [2][12] Feed and Animal Health - The average price of pig feed is 2.72 CNY/kg, with no change from the previous week. The report also provides insights into the prices of various feed types for poultry and livestock [50][52]

Investment Rating - The report maintains an "Overweight" rating for the pet industry, indicating that the industry index is expected to outperform the market index by over 10% in the next six months [4]. Core Insights - The pet industry in China is projected to continue its rapid growth, with the urban pet consumption market expected to increase from 170.8 billion yuan in 2018 to 300.2 billion yuan by 2024, reflecting a CAGR of approximately 9.9% [3]. - The pet food market is anticipated to grow from 89.1 billion yuan to 158.5 billion yuan during the same period, with a CAGR of about 10.1% [3]. - The pet healthcare market, including vaccines and medications, is expected to see significant growth, with a projected increase from 8.54 billion yuan to 37.22 billion yuan, representing a CAGR of 27.8% [3]. - The report highlights that the pet ownership penetration rate in China is still relatively low compared to mature markets, indicating substantial room for growth [3]. Market Dynamics - The pet ownership demographic is shifting towards younger generations, with post-90s pet owners constituting 41.2% and post-00s pet owners rising to 25.6% [3]. - The report notes that the pet industry in China is characterized by a low concentration of market players, with the top three companies holding only 3.6% of the market share [3]. - The competitive landscape is fragmented, with numerous small and medium-sized enterprises alongside established brands like Guai Bao Pet and Zhong Chong Co [3]. Investment Recommendations - The report suggests focusing on key players in the pet industry, including Guai Bao Pet (301498), Zhong Chong Co (002891), Yi Yi Co (001206), Yuan Fei Pet (001222), Tian Yuan Pet (301335), and Pu Lai Ke (603566) [3].

Core Viewpoint - The veterinary raw material drug market in China is expected to grow significantly, with a projected market size of approximately 185.1 billion yuan in 2024 and around 200 billion yuan in 2025, driven by increased demand and favorable economic conditions [1][8]. Industry Characteristics and Classification - Veterinary raw material drugs are pharmacologically active substances used directly in the manufacture of veterinary drug formulations, characterized by specificity, regulatory requirements, and high technical barriers [2][4]. - They can be classified by chemical properties into synthetic raw materials, biotechnological raw materials, and natural extracts, and by usage into antimicrobial drugs, antiparasitic drugs, antipyretic analgesics, and diagnostic/treatment aids [4][5]. Current Development Status - The veterinary drug industry in China has rapidly developed, becoming a significant part of the global veterinary drug market, with a projected market size of approximately 600 billion yuan in 2024 and 635 billion yuan in 2025 [6][8]. Market Size and Growth - The veterinary raw material drug market is expected to see a growth from 185.1 billion yuan in 2024 to 200 billion yuan in 2025, reflecting a recovery in demand and controlled supply [8][10]. Market Segmentation - Antimicrobial drugs dominate the veterinary raw material drug market, holding an 84% market share, while antiparasitic drugs account for about 11% [10]. Industry Chain - The industry chain includes upstream components such as basic chemical raw materials and intermediates, midstream production of raw materials through chemical synthesis and fermentation, and downstream processing into veterinary drug formulations for livestock and pet healthcare [12]. Competitive Landscape - The veterinary raw material drug industry in China has a low concentration level, with major companies including Haisheng Pharmaceutical, Qihui Pharmaceutical, Guobang Pharmaceutical, and Puluo Pharmaceutical, among others [14][16]. - The industry is experiencing a shift towards larger, more capable firms as regulatory standards improve, leading to a potential increase in market concentration [14]. Key Enterprises - Guobang Pharmaceutical reported a revenue of 1.831 billion yuan from animal health raw materials in 2024, with a gross margin of 18.86% [16]. - Haisheng Pharmaceutical achieved a revenue of 112 million yuan from raw materials in 2024, with a gross margin of 36.28% [18]. Technology Development Trends - The production of raw materials and intermediates requires significant investment in research and development to improve process technology and compete in higher-margin sectors [20].

Market Overview - The A-share market shows strong upward momentum, with a focus on sectors such as hydropower construction, rare earths, and military industry [4][8] - The total market capitalization of the Shanghai Composite Index is 6,846.04 billion, with a PE ratio of 12.65 and a PB ratio of 1.31 [3] - The Shenzhen Component Index has a total market capitalization of 2,382.45 billion, with a PE ratio of 21.24 and a PB ratio of 2.25 [3] Economic Insights - In the first half of 2025, China attracted foreign investment of 423.23 billion RMB, with a year-on-year decrease of 15.2% [20] - The number of small and medium-sized enterprises in Hunan Province has surpassed 2.13 million, an increase of 156,200 compared to the same period last year [48] Industry Dynamics - The clinical trial for the African swine fever subunit vaccine has been approved, marking a significant step towards commercialization [31] - The first domestic cat trivalent vaccine has received approval for new veterinary drug registration, indicating progress in domestic pet health products [33] - The lithium battery industry in China saw a shipment volume increase of over 40% year-on-year in the first half of 2025, with a total shipment of 776 GWh [37][39] Company Updates - Sanqi Interactive Entertainment has appointed Zeng Kaitian as the new general manager, indicating a leadership change within the company [43][44] - Feiwo Technology has initiated its first share buyback, repurchasing 50,000 shares as part of its stock incentive plan [45][46]

Summary of Conference Call Records Industry Overview - The conference call primarily discusses the **pork industry** and the **pet supply chain** market in China, focusing on recent trends, regulatory impacts, and market dynamics. Key Points on the Pork Industry 1. **Pork Price Trends**: Pork prices are on a downward trend due to supply influences, with prices fluctuating around 14 RMB after a brief increase to over 15 RMB in June. This aligns with expectations of high annual output and piglet replenishment rates, indicating limited short-term price increases [1][2]. 2. **Regulatory Impact**: The government aims to stabilize pork supply and prevent price surges, with large farming enterprises playing a crucial role. Stricter measures may be implemented, including environmental regulations and financial controls, to achieve long-term stabilization [1][5]. 3. **Market Dynamics**: The pork industry is undergoing a natural price decline and capacity reduction process. Leading companies like Muyuan Foods are becoming more resilient in the competitive landscape, transitioning from cyclical to value stocks, making them attractive for long-term investment [1][7]. 4. **Production Forecast**: The pork price outlook for Q3 and H2 remains cautious, with high production levels expected to persist. The growth in output is anticipated to keep prices low, as the supply of pigs is not expected to decrease significantly in the short term [4][6]. 5. **Vaccination Developments**: The approval of clinical trials for African swine fever subunit vaccines is a positive development, although the timeline for market availability remains uncertain. This could directly impact companies like BioFeng and Zhongmu [3][15]. Key Points on the Pet Supply Chain 1. **Market Performance**: The pet consumption market showed strong performance in H1 2025, with total spending reaching approximately 77.3 billion RMB, an 8.8% year-on-year increase. Online sales dominate, while offline pet store sales grew only about 1% [8][9]. 2. **Trends in Pet Food**: The pet food market is experiencing product diversification and precision in consumer demand. High-end products and scientific pet care concepts are driving market upgrades, with categories like baked food seeing rapid growth [9][12]. 3. **Emerging Brands**: New brands are quickly rising by meeting consumer needs, indicating a shift towards higher quality and specialized products in the pet food sector [9][12]. 4. **Future Directions**: Domestic pet brands are expected to continue moving towards mid-to-high-end markets, focusing on scientific pet care and product upgrades to maintain growth. The competitive landscape in lower-end markets remains intense [12][14]. 5. **Market Outlook**: The pet industry outlook is optimistic, driven by differentiated products and strong domestic demand. The annual growth rate of new pet owners is stable at around 8%, with online sales growth of 15-16% last year [13][14]. Additional Insights - The pork industry is expected to see a gradual transition towards stable production levels, benefiting leading companies with lower costs and higher certainty in performance [6][7]. - The approval of the African swine fever vaccine is a significant milestone, but the path to market remains complex and uncertain, necessitating close monitoring of developments [15][17]. - The pet supply chain is poised for rapid growth over the next three to five years, presenting a compelling investment opportunity as consumer preferences evolve [14].

Group 1: Shareholder Actions - Shareholder Shen Yougen plans to transfer 159 million shares of Dongfang Caifu, accounting for 1% of the company's total share capital [2] - Major shareholder Suzhou International Development Group and its affiliates are among the specific targets for East Wu Securities' planned A-share issuance, which aims to raise up to 6 billion yuan [2] - Longhong High-Tech intends to acquire 100% equity of Guangxi Changke through a combination of share issuance, convertible bonds, and cash payments [2] Group 2: Corporate Performance - Nanjing Gaoke reported a contract sales amount of 1.021 billion yuan for the first half of 2025, representing a year-on-year increase of 729.83% [3] - The company achieved a contract sales area of 68,500 square meters in the first half of 2025, up 2437.04% year-on-year [3] Group 3: Management Changes and Legal Issues - Chairman Guo Baichun of Yaqi International has been detained for suspected embezzlement and abuse of power, but the company's operations remain normal [3] - *ST Yazhen announced that its verification work has been completed, and its stock will resume trading on July 21 [3] Group 4: Financial Performance Forecasts - Jiabiyou expects a 57.61% year-on-year increase in net profit for the first half of 2025 [7] - SF Holding reported a 14.24% year-on-year increase in revenue from its express logistics business for June 2025 [7] - Double杰 Electric anticipates a net profit increase of 16.03% to 39.23% for the first half of 2025 [7]

Group 1 - Senyuan Electric signed a strategic cooperation agreement with Xuchang Digital Supply Chain Management Co., aiming for annual business cooperation not exceeding 500 million yuan over 36 months [1] - CICC's subsidiary, CICC Wealth, reported a net profit of 987 million yuan for the first half of the year, with total assets of 193.37 billion yuan [2] - Shuangjie Electric expects a net profit of 100 million to 120 million yuan for the first half of the year, representing a year-on-year increase of 16.03% to 39.23% [3][4] - Shentong Technology reported a net profit of 64.28 million yuan for the first half of the year, a year-on-year increase of 111.09% [5] - Suqian Nongfa's net profit for the first half of the year decreased by 27.72% to 213 million yuan [6] Group 2 - Fuan Pharmaceutical expects a net profit decline of 39.95% to 53.81% for the first half of the year, estimating between 100 million to 130 million yuan [8] - Xingwang Yuda anticipates a net loss of 11 million to 21 million yuan for the first half of the year [9] - Pulaike received a new veterinary drug registration certificate for a vaccine aimed at preventing chicken diseases [10] - Yuandong Biological's ephedrine injection received a drug registration certificate for treating low blood pressure during anesthesia [11] - Suqian Liansheng's subsidiary obtained two invention patent certificates [12] Group 3 - Oke Technology signed a 176 million yuan equipment order with Jiangxi Tianhong New Materials [13] - Publishing Media announced the resignation of its chief accountant due to work changes [15] - Zhongxin Co. plans to use 40 million yuan of idle funds for cash management [16] - Huiyun Titanium plans to use up to 58 million yuan of idle convertible bond funds for cash management [18] - Haineng Technology intends to apply for a credit facility of up to 200 million yuan from a bank [20] Group 4 - Jiabiou expects a net profit increase of 57.61% for the first half of the year, estimating around 107 million yuan [21] - Nanjing Gaoke reported a 1185% year-on-year increase in contract sales area for the second quarter [22] - Shuguang Co. received approval for a specific stock issuance application [23] - Huadong Pharmaceutical's subsidiary received approval for a clinical trial of a new drug targeting advanced solid tumors [23] - Quicheng Co. plans to invest 900 million yuan in two new projects [25] Group 5 - Shenlian Biological's vaccine for avian adenovirus received a new veterinary drug registration certificate [26] - Rike Chemical signed a strategic cooperation framework agreement with Dongming Petrochemical [28] - Jincheng Pharmaceutical's subsidiary received a renewed tobacco production license [29] - Magmi Te's stock issuance application was accepted by the Shenzhen Stock Exchange [29] - Zhongyin Securities received approval to issue bonds totaling up to 14 billion yuan [29] Group 6 - Hewei Electric's executives plan to reduce their holdings by a total of 2.24% of the company's shares [44] - Guo Wang Xintong reported a net profit of 266 million yuan for the first half of the year, a decrease of 10.82% [45] - Guo Wang Xintong's subsidiary won a 966 million yuan tender from the State Grid [46] - Jicheng Electronics won contracts worth approximately 83.79 million yuan from the State Grid [48] - Helen Piano is planning a change of control, leading to a temporary stock suspension [48]

Investment Rating - The report maintains an investment rating of "Outperform" for the agricultural, forestry, animal husbandry, and fishery industry [1][9]. Core Insights - The agricultural, forestry, animal husbandry, and fishery industry is currently experiencing weak market demand and low prices for livestock and poultry, particularly in the pig farming sector, which has seen a significant price drop [9][12]. - The report highlights that the industry is currently undervalued, with price-to-earnings (P/E) and price-to-book (P/B) ratios below historical averages, suggesting potential for valuation recovery [9][12]. Summary by Sections Market Review - In June 2025, the agricultural, forestry, animal husbandry, and fishery index rose by 1.13%, underperforming the CSI 300 index, which increased by 2.50%, resulting in a relative underperformance of 1.37 percentage points [9][12]. - The planting sector showed the highest gains, while the animal health processing sector experienced the largest declines [12]. Livestock Farming Data Tracking - **Pig Farming**: The average trading price for pigs in June 2025 was 14.28 yuan/kg, down 2.16% month-on-month and 21.81% year-on-year. The market shifted to a surplus situation, leading to price declines [9][17]. - **Broiler Chickens**: The average price for broiler chicks in June 2025 was 2.15 yuan/chick, reflecting a slight decrease. The cautious replenishment of chicks due to declining prices further pressured the market [9][27]. Pet Food Sector - In May 2025, pet food exports totaled 28,900 tons, a year-on-year decrease of 5.52%. The cumulative export value for the first five months was $581 million, up 4.59% year-on-year [9][34]. Major Agricultural Product Price Tracking - The report includes tracking of key agricultural product prices, indicating fluctuations in corn, wheat, and soybean meal prices during June 2025 [9][39]. Industry Dynamics and Company News - The report outlines significant events in the industry, including a decrease in grain imports and ongoing developments in the seed industry aimed at enhancing agricultural productivity [9][46]. - Key announcements from listed companies in the sector include various asset restructuring and financing activities [9][48].